scholarly journals Distribution of five SVOCs in a model room: effect of vacuuming and air cleaning measures

2019 ◽  
Vol 21 (8) ◽  
pp. 1353-1363 ◽  
Author(s):  
Erik Uhde ◽  
Deniz Varol ◽  
Birte Mull ◽  
Tunga Salthammer
Keyword(s):  
Air Cleaning ◽  
Model Room

We monitored the distribution of SVOCs in model rooms in dependence of temperature and cleaning measures over a period of six months.

Ozone Air Cleaning

1920 ◽  
Vol 1 (4supp) ◽  
pp. 382-382
Author(s):  
E. S. Hallett
Keyword(s):  
Air Cleaning

scholarly journals Oxidation of Aqueous Toluene by Gas-Phase Pulsed Corona Discharge in Air-Water Mixtures Followed by Photocatalytic Exhaust Air Cleaning

Catalysts ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 549
Author(s):  
Maarja Kask ◽  
Marina Krichevskaya ◽  
Sergei Preis ◽  
Juri Bolobajev
Keyword(s):  
Corona Discharge ◽  
Gas Phase ◽  
Contact Time ◽  
Closed Loop ◽  
Simultaneous Treatment ◽  
Pulsed Corona Discharge ◽  
Air Cleaning ◽  
Pulsed Corona ◽  
Volatile Organic ◽  
Gaseous Toluene

The treatment of wastewaters containing hazardous volatile organic compounds (VOCs) requires the simultaneous treatment of both water and air. Refractory toluene, extensively studied for its removal, provides a basis for the comparison of its abatement methods. The oxidation of aqueous toluene by gas-phase pulsed corona discharge (PCD) in combination with the subsequent photocatalytic treatment of exhaust air was studied. The PCD treatment showed unequalled energy efficiencies in aqueous and gaseous toluene oxidation, reaching, respectively, up to 10.5 and 29.6 g·kW−1·h−1. The PCD exhaust air contained toluene residues and ozone in concentrations not exceeding 0.1 and 0.6 mg·L−1, respectively. As a result of the subsequent photocatalytic treatment, both airborne residues were eliminated within a contact time with TiO2 as short as 12 s. The results contribute to the possible application of the studied approach in closed-loop energy-saving ventilation systems.

scholarly journals Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device

2021 ◽  
pp. 107815522110306
Author(s):  
Galit Levin ◽  
Paul JM Sessink
Keyword(s):  
Activated Carbon ◽  
Closed System ◽  
Membrane Filter ◽  
Drug Transfer ◽  
Glass Vessel ◽  
Air Cleaning ◽  
No Release ◽  
Activated Carbon Filter ◽  
Carbon Filter ◽  
Transfer Device

Purpose The purpose of this study was to test the efficacy of ChemfortTM, an air filtration closed-system drug transfer device to prevent release of chemotherapy drug vapors and aerosols under extreme conditions. The air cleaning system is based on the adsorption of drug vapors by an activated carbon filter in the Vial Adaptor before the air is released out of the drug vial. The functionality of the carbon filter was also tested at the end of device’s shelf life, and after a contact period with drug vapors for 7 days. Cyclophosphamide and 5-fluorouracil were the chemotherapy drugs tested. Methods The Vial Adaptor was attached to a drug vial and both were placed in a glass vessel. A needle was punctured through the vessel stopper and the Vial Adaptor septum to allow nitrogen gas to flow into the vial and to exit the vial via the air filter into the glass vessel which was connected to a cold trap. Potential contaminated surfaces in the trap system were wiped or rinsed to collect the escaped drug. Samples were analyzed using liquid chromatography tandem mass spectrometry. Results Cyclophosphamide and 5-fluorouracil were detected on most surfaces inside the trap system for all Vial Adaptors without an activated carbon filter. Contamination did not differ between the Vial Adaptors with and without membrane filter indicating no effect of the membrane filter. The results show no release of either drug for the Vial Adaptors with an activated carbon filter even after 3 years of simulated aging and 7 days of exposure to drug vapors. Conclusions Validation of air cleaning CSTDs is important to secure vapor and aerosol containment of chemotherapy and other hazardous drugs. The presented test method has proven to be appropriate for the validation of ChemfortTM Vial Adaptors. No release of cyclophosphamide and 5- fluorouracil was found even for Vial Adaptors after 3 years of simulated aging and 7 days of exposure to drug vapors.

Sign in / Sign up

Export Citation Format

Share Document